T. Rowe Price Investment Management, Inc. Bridge Bio Pharma, Inc. Transaction History

T. Rowe Price Investment Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$23.0 - $31.04 $26.9 Million - $36.3 Million	-1,168,748 Reduced 80.88%	276,369 $7 Million
Q1 2024 May 15, 2024	BUY	$27.35 - $40.45 $269,041 - $397,906	9,837 Added 0.69%	1,445,117 $44.7 Million
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $10.6 Million - $19.3 Million	439,648 Added 44.16%	1,435,280 $57.9 Million
Q3 2023 Nov 14, 2023	BUY	$16.89 - $35.01 $16.8 Million - $34.9 Million	995,632 New	995,632 $26.3 Million

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.92B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.